SCHEMBL7858703

SCHEMBL7858703

CC(C)N(C(C)C)[P@@](O)OCCC#N

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.30
NLRP3 Q96P20 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL252367 1.00 TSHR (0.30) TSHRNLRP3
SCHEMBL7262903 1.00 TSHR (0.30) TSHRNLRP3
Hydrochloric Acid SCHEMBL25380883 0.98
SCHEMBL5067027 0.92
SCHEMBL5063697 0.92
Glycerin SCHEMBL7951846 0.90
SCHEMBL5065012 0.90
SCHEMBL26653603 0.90
SCHEMBL23384350 0.90 TSHR (0.31) TSHR
SCHEMBL9235878 0.89

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110287550-A1 Method for continuously monitoring solution-phase synthesis of oligonucleotide NATIONAL SUN YAT-SEN UNIVERSITY (TW) 2011-11-24 US disclosed
US-20010034329-A1 Antisense modulation of focal adhesion kinase expression ISIS PHARMACEUTICALS, INC. 2001-10-25 US disclosed
US-20010029250-A1 Antisense oligonucleotide modulation of STAT3 expression IONIS PHARMACEUTICALS, INC. 2001-10-11 US disclosed